Literature DB >> 118935

Enzymatic induction of interferon production by galactose oxidase treatment of human lymphoid cells.

F Dianzani, T M Monahan, A Scupham, M Zucca.   

Abstract

Human lymphocyte cultures produced large amounts of interferon after treatment with the enzyme galactose oxidase. Interferon production was detectable as early as 3 h after enzymatic treatment and reached a level of about 10(4) reference units 20 to 24 h later. Galactose oxidase-induced interferon appeared to be immune interferon on the basis of acid lability, lack of neutralization by antibody to leukocyte interferon, and slow kinetics of activation of the cellular antiviral state. Interferon production was inhibited to the same extent (99%) by pretreatment of the cells with beta-galactosidase or with neuraminidase followed by beta-galactosidase, suggesting that the critical event for activation of interferon production is the oxidation of exposed galactose residues on lymphocyte membrane.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 118935      PMCID: PMC414702          DOI: 10.1128/iai.26.3.879-882.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Galactose oxidase-induced blastogenesis of human lymphocytes and the effect of macrophages on the reaction.

Authors:  M Biniaminov; B Ramot; E Rosenthal; A Novogrodsky
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

2.  Nonsensitized lymphocytes produce leukocyte interferon when cultured with foreign cells.

Authors:  J E Blalock; M P Langford; J Georgiades; G J Stanton
Journal:  Cell Immunol       Date:  1979-03-01       Impact factor: 4.868

3.  The requirement for cell surface galactosyl residues during oxidative activation of normal and chronic lymphocytic leukemia lymphocytes.

Authors:  T M Monahan; C W Abell
Journal:  Exp Cell Res       Date:  1978-10-01       Impact factor: 3.905

4.  Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans.

Authors:  L Rasmussen; T C Merigan
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

Review 5.  Mitogen and antigen induction of interferon in vitro and in vivo.

Authors:  L B Epstein
Journal:  Tex Rep Biol Med       Date:  1977

6.  Fluorescence-activated cell sorting of human T and B lymphocytes. II. Identification of the cell type responsible for interferon production and cell proliferation in response to mitogens.

Authors:  L B Epstein; H W Kreth; L A Herzenberg
Journal:  Cell Immunol       Date:  1974-06       Impact factor: 4.868

7.  Induction of lymphocyte transformation by sequential treatment with neuraminidase and galactose oxidase.

Authors:  A Novogrodsky; E Katchalski
Journal:  Proc Natl Acad Sci U S A       Date:  1973-06       Impact factor: 11.205

8.  Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity.

Authors:  J S Youngner; S B Salvin
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

9.  Large-scale production and partial purification of mouse immune interferon.

Authors:  L C Osborne; J A Georgiades; H M Johnson
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

10.  Transformation of human peripheral lymphocytes by galactose oxidase.

Authors:  J F Dixon; J W Parker; R L O'Brien
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

View more
  14 in total

1.  Human immune interferon: induction in lymphoid cells by a calcium ionophore.

Authors:  F Dianzani; T M Monahan; J Georgiades; J B Alperin
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

2.  Membrane alteration responsible for the induction of gamma interferon.

Authors:  F Dianzani; T M Monahan; M Santiano
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

3.  Role of calcium in gamma interferon induction: inhibition by calcium entry blockers.

Authors:  F Dianzani; M R Capobianchi; J Facchini
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

4.  Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta.

Authors:  A Dolei; M R Capobianchi; F Ameglio
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

5.  Induction of human gamma interferon by structurally defined polypeptide fragments of group A streptococcal M protein.

Authors:  D A Weigent; E H Beachey; T Huff; J W Peterson; G J Stanton; S Baron
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

6.  Interferon production in primary immunodeficiencies.

Authors:  P M Matricardi; M R Capobianchi; R Paganelli; J Facchini; M C Sirianni; R Seminara; F Dianzani; F Aiuti
Journal:  J Clin Immunol       Date:  1984-09       Impact factor: 8.317

7.  Detection of gamma interferon in the sera of patients with Behçet's disease.

Authors:  S Ohno; F Kato; H Matsuda; N Fujii; T Minagawa
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

8.  Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells.

Authors:  R Devos; H Cheroutre; Y Taya; W Degrave; H Van Heuverswyn; W Fiers
Journal:  Nucleic Acids Res       Date:  1982-04-24       Impact factor: 16.971

9.  Stimulation of human gamma interferon production by diterpene esters.

Authors:  Y K Yip; R H Pang; J D Oppenheim; M S Nachbar; D Henriksen; I Zerebeckyj-Eckhardt; J Vilcek
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

10.  Cell-mediated cytotoxicity in glioma-bearing patients: differential responses of peripheral blood mononuclear cells to stimulation with interleukin-2 and microbial antigen.

Authors:  C Ausiello; A Maleci; G C Spagnoli; G Antonelli; A Cassone
Journal:  J Neurooncol       Date:  1988-12       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.